NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

Shutterstock image of woman doing fingertip test
Four North Carolina universities have teamed up to win a $5.7 million federal grant for diabetes research.
Venture Connect Online logo
CED's Venture Connect Online starts today and runs for the next three weeks, giving over 90 growth-stage companies exposure to potential investors from around the world.
Banner logo
Banner Life Sciences, a High Point pharmaceutical company, has gained final regulatory approval of a drug for treating multiple sclerosis.
Chimerix logo
Durham-based Chimerix is another step closer to getting the final go-ahead for its novel smallpox treatment.
Chimerix logo
Durham-based Chimerix has gotten the green light from the FDA to test an investigational cancer drug to treat COVID-19 patients.
Krista Covey
First Flight Venture Center has named Krista Covey as the incubator’s new president, effective May 18. 
Heat Bio logo
For those feeling the health and economic heat from COVID-19 – and that’s just about everyone – Heat Biologics says it could soon offer up a potential solution.
LabCorp photo
A LabCorp blood test that helps identify individuals who’ve been exposed to the COVID-19 coronavirus is now broadly available.
Prototype of COVID-19 test slide
Duke University biomedical engineers are using an NSF grant to convert a rapid testing platform originally designed to detect Ebola to catch antigens to COVID-19.
RedHill logo
RedHill Biopharma, an Israeli specialty company with U.S. headquarters in Raleigh, says all six COVID-19 patients who recently received its investigative drug, opaganib, got better. 
Shutterstock tomato image
Wake Forest University researchers have a $3 million NSF grant to study why tomato plants won’t bear fruit when things get hot.
Metabolon researchers in PPE
Morrisville precision health company Metabolon is working with a Seattle non-profit to study variations in COVID-19 outcomes and target potential therapies to deal with those variations.
AskBio generic photo
AskBio has acquired BrainVectis, a French company that is developing a potential gene therapy for Huntington’s disease, a fatal genetic disease of the brain.
Grifols' 233-acre manufacturing site in Clayton.
People who have recovered from COVID-19 may donate potentially lifesaving plasma at UNC, and Grifols is also collecting it at plasma donor sites elsewhere around the country.
LabCorp lab photo
Healthcare workers and first responders who have symptoms of COVID-19 now can use a LabCorp kit to self-test for the coronavirus at home.